Aaron Pearce
Analyst · Wells Fargo. Your line is now open
Thank you, Michael and good morning, everyone. The financial review starts on slide number three. Sales increased to 2.9% to $297.5 million in the fourth quarter, which consisted of organic sales growth of 2.5% and an increase of 1% from foreign currency translation, partially offset by a decrease of 0.6% from the sale of our Runelandhs in Sweden. We increased our investment in research and development once again this quarter. R&D expense was $11.7 million, which was an increase of 6.3% over last year's fourth quarter. Our trend of improved profitability continued this quarter as well, excluding the $4.7 million gain on divestiture pre-tax earnings increased 13% to $40.6 million compared to $35.9 million in last year's fourth quarter. The profit improvement was driven by organic sales growth and profit growth in both our IDS and WPS businesses, as well as our continued focus on driving sustainable efficiency gains throughout our SG&A structure. Net earnings finished at $35 million this quarter compared to $25.2 million in the fourth quarter of last year. Excluding the gain on the divestiture net earnings would have been $30.3 million, which is an increase of 20% over last year's fourth quarter. Our tax rate excluding the gain on the divestiture was 25.4%, which compares to a tax rate of 29.7% in last year's fourth quarter. This quarter EPS benefitted approximately $0.09 from the sale of Runelandhs. Excluding this gain, EPS would have been $0.57, which is an increase of 18.8% over the $0.48 of EPS recorded in last year's fourth quarter. Our cash generation continues to be strong, cash flow from operating activities was $53.8 million this quarter, which was equal to 154% of net earnings. Overall, we had a strong finish to fiscal 2018. We grew organically, we realized efficiency gains in our SG&A structure, we generated strong cash flow, we increased our investment in R&D and we increased our investments in machinery and equipment to further drive efficiencies and automation within our manufacturing facilities. On slide number four, you'll find our quarterly sales trends. Total sales grew 2.9% and organic sales increased 2.5%. We're building positive sales momentum in both our IDS and WPS segments, which we're expecting to continue into fiscal 2019. Our gross profit trending is outlined on slide number five. Our gross profit margin was effectively flat at 49.6% this quarter, compared to 49.7% in the fourth quarter of last year. Slide number six details our SG&A expense trending. SG&A was $90.9 million this quarter compared to $96.5 million in the fourth quarter of last year. Excluding the gain on the divestiture, SG&A expense was $95.6 million, which is a decrease of approximately $900,000 from last year's fourth quarter. This decrease is a direct result of our ongoing efforts to improve processes and drive sustainable efficiency gains throughout our SG&A structure. Looking forward, we expect that our general and administrative expenses will continue this general downward trend, while we reinvest the savings into R&D resources to drive future sales growth. Slide number seven illustrates the trending of our investments in R&D. We increased our investments in R&D once again this quarter from $11 million in last year's fourth quarter to $11.7 million this year. We're committed to new product development, we launched another new printer this quarter, and we have an improved pipeline with more products planned to launch in fiscal 2019. We believe investments in growing the business organically will ultimately have the highest rate of return and are critical to growing sales consistently over the long-term. Moving to slide number eight, you'll find our quarterly trending of pre-tax earnings. Excluding the gain on the divestiture, this quarter, we increased pre-tax earnings by $4.7 million or 13%. This marks our 12 consecutive quarter of pre-tax earnings improvement. Slide number nine shows the trending of our quarterly earnings per share and net earnings. Excluding the gain on divestiture, our diluted EPS would have been $0.57 this quarter, compared to $0.48 in last year's fourth quarter, an increase of 18.8%. Excluding the gain on divestiture, our tax rate was 25.4% this quarter. As we look ahead into fiscal 2019, we expect our tax rate to be in the mid-20% range, as we realize benefits from the U.S. tax reform that was signed into law in December of 2017. However, this tax rate is subject to further refinement as the U.S. Treasury continues to come out with various interpretations and implementation guidance. Moving along to slide number 10, you'll find a summary of our cash generation. We generated $53.8 million of cash flow from operating activities, compared to $52.9 million in last year’s fourth quarter. Free cash flow was $46.8 million this quarter, compared to $48.6 million in the same quarter last year. We continued our trend of generating cash flow in excess of net earnings. In the fourth quarter cash flow from operating activities was equal to 154% of net earnings and free cash flow is equal to 134% of net earnings. Our primary uses of cash were to invest in organic sales generating activities, to strengthen our balance sheet by paying down debt, and to return funds to our shareholders in the form of dividends. This brings us to slide number 11. This slide outlines the trending of our net cash position and provides a snapshot of our debt structure at the end of our fiscal year. We increased our net cash position by more than $100 million this year, while increasing both our investments in R&D and in capital expenditures, which is a testament to our strong cash generating ability. At the end of the year, our net cash position was $128.8 million. As we look at deploying our cash, our approach to capital allocation is disciplined and patient. First, we use our cash to fund organic opportunities throughout the cycle, which includes funding investments in new product development, sales generating resources, IT improvements, capability enhancing capital expenditures and capital expenditures to increase efficiency and increase automation in our factories. Second, we focus on returning cash to our shareholders in the form of dividends. After funding organic investments in dividends, we then patiently deploy our cash in a disciplined manner for acquisitions, where we believe we have strong synergistic opportunities, and we use our cash to improve shareholder returns through opportunistic share repurchases. We have nearly 2 million shares authorized for repurchase as of July 31st. Overall, our cash generation is strong, our balance sheet is strong and we’re focused on driving long-term value for our shareholders through our disciplined allocation of capital. Before moving to our fiscal 2019 EPS guidance, I’d like to provide a look back at our fiscal 2018 financial results, which is on slide number 12. This year, we reported organic sales growth in each quarter and grew 2.6% organically for the year. We increased our GAAP pre-tax earnings by 20% and if you exclude the gain on the sale of Runelandhs, we -- than our pre-tax earnings grew 16.4%. We returned our Workplace Safety business to organic sales growth, with organic sales growth increasing 0.7% and WPS segment profit increasing 24.1%. And we generated $143 million of cash flow from operating activities, which equates to approximately 157% of net earnings. We continue to execute efficiency improvements, which is evidenced in our reduced SG&A as a percent of sales, we have more opportunities to reduce our G&A expense and our back office selling activities, while improving our processes around the customer buying experience. We also increased our investments in R&D, which was up 14% this year. This is directly in line with our strategy to drive long-term sales growth through the development of a steady pipeline of new product introductions throughout our businesses. Overall, our FY18 financial results were strong and we have very strong positive momentum going into fiscal 2019. Slide number 13, introduces our diluted earnings per share guidance for our fiscal year ending July 31, 2019. We expect earnings per diluted Class A Nonvoting Common Share to range from $2.15 to $2.25 per share and we expect organic sales growth to range from 2% to 4%. Included in our FY19 guidance, is an increase in R&D investments of approximately 7%, we expect our income tax rate to be in the mid-20% range, we expect depreciation and amortization expense of approximately $26 million and capital expenditures of approximately $35 million. Included in our CapEx guidance is approximately $10 million of expenditures related to the construction of certain facilities that are currently leased. Excluding these facility construction cost, our CapEx is still running a bit higher than our historical averages, as we continue to invest in factory automation and improved manufacturing capabilities. Our guidance is based on foreign currency exchange rates as of July 31, 2018. Based on these exchange rates, we expect that foreign currency will negatively impact our FY19 results by approximately $0.12 per share, which is of course built into our guidance range of $2.15 to $2.25 per share. We are not anticipating any restructuring charges and we are not excluding any one-time items from this guidance. I’ll now turn the call back over to Michael to cover our divisional results and provide some closing comments, before turning the call over to Q&A. Michael?